Cargando…

Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma

OBJECTIVE: To analyze the correlation between metanephrine and normetanephrines (MNs) and subclinical myocardial injuries (SMI) diagnosed by low left ventricular global longitudinal strain (LV GLS) in patients with pheochromocytoma and paraganglioma (PPGL). METHODS: Seventy-six patients who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yang, Chen, Chuyun, Han, Wencong, Zhang, Yan, Zhang, Zheng, Yang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552905/ https://www.ncbi.nlm.nih.gov/pubmed/36237312 http://dx.doi.org/10.3389/fonc.2022.1024342

Ejemplares similares

Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma
por: Gupta, Poonam, et al.
Publicado: (2015)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
por: Ahn, Jiyeon, et al.
Publicado: (2021)

Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma
por: Prego, Maria Teresa, et al.
Publicado: (2023)

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma
por: Zhou, Jing, et al.
Publicado: (2021)

Commutability Assessment of Processed Human Plasma Samples for Normetanephrine and Metanephrine Measurements Based on the Candidate Reference Measurement Procedure
por: Deng, Yuhang, et al.
Publicado: (2022)

Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma
por: Raber, Wolfgang, et al.
Publicado: (2020)

Pheochromocytoma with Negative Metanephrines: A Rarity and the Significance of Dopamine Secreting Tumors
por: Bozin, Michael, et al.
Publicado: (2017)

An LC-MRM assay for the quantification of metanephrines from dried blood spots for the diagnosis of pheochromocytomas and paragangliomas
por: Richard, Vincent R., et al.
Publicado: (2020)

Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas
por: Zeng, Hongyu, et al.
Publicado: (2022)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
por: Jin, Bo, et al.
Publicado: (2022)

Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
por: López-Gómez, Javier, et al.
Publicado: (2016)

A Predictive Nomogram for Early Death in Pheochromocytoma and Paraganglioma
por: Li, Huiyang, et al.
Publicado: (2022)

Pheochromocytoma and Paraganglioma: Current Functional and Future Molecular Imaging
por: Blanchet, Elise M., et al.
Publicado: (2012)

Interpreting Normetanephrines-the Significance of Clinical Context
por: Kumar, Nitya, et al.
Publicado: (2021)

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2022)

External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma
por: Vogel, Jennifer, et al.
Publicado: (2014)

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
por: Jha, Abhishek, et al.
Publicado: (2019)

Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
por: Brazda, Peter, et al.
Publicado: (2022)

Peptide receptor radionuclide therapy in advanced Pheochromocytomas and Paragangliomas: a systematic review and meta-analysis
por: Su, Dan, et al.
Publicado: (2023)

The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study
por: Duan, Sai-Li, et al.
Publicado: (2022)

Risk factors for postoperative complications after pheochromocytoma and/or paraganglioma: a single-center retrospective study
por: Ma, Lulu, et al.
Publicado: (2023)

FRI217 False Negative Plasma Metanephrines In A Patient With A Bladder Paraganglioma
por: King, Thomas F J, et al.
Publicado: (2023)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
por: Sawka, Anna M, et al.
Publicado: (2005)

Urinary and Plasma Catecholamines and Metanephrines in Dogs with Pheochromocytoma, Hypercortisolism, Nonadrenal Disease and in Healthy Dogs
por: Salesov, E., et al.
Publicado: (2015)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

MON-220 Real World Performance of Urinary and Plasma Metanephrine Assays in Diagnosing Phaeochromocytoma/Paraganglioma
por: Deyab, Eithar, et al.
Publicado: (2020)

Correlation between catecholamines and echocardiographic parameters in patients with pheochromocytoma and paraganglioma
por: Wang, Chunyan, et al.
Publicado: (2022)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
por: Pang, Ying, et al.
Publicado: (2019)

Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
por: van den Berg, Marit F., et al.
Publicado: (2023)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vhv0utelbkviue3uv574gc44v